Shares of Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) edged up 2% after the company shared encouraging interim results from two Phase 2 trials evaluating its investigational mRNA therapy, ...

Investing.com -- Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) stock rose 2% following positive interim results from two Phase 2 clinical trials of its ARCT-810 mRNA therapeutic for ornithine ...

What lies at the core of the crypto market: speculation or innovation? Like any financial market, crypto moves in cycles. Within those cycles, different trends come into play, often shifting the ...

Advice Ask Anna: Hookup culture burnout and crush cycles: Pride edition Published: Jun. 29, 2025, 9:00 a.m.

However, a re-examination of the cell walls of some strains of plant pathogenic corynebacteria showed that these two amino-acids may be replaced in some cases by ornithine or diaminobutyric acid ...

Ornithine decarboxylase (ODC) is a pyridoxal 5‘-phosphate (PLP) dependent enzyme that catalyzes the decarboxylation of l-Orn to putrescine, a rate-limiting step in the formation of polyamines. The ...